8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Dec 20, 2021 · 4y ago · Accession 0001493152-21-032048
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Immix Biopharma, Inc.
- Ticker
- IMMX
- CIK
- 1873835
- Form type
- 8-K
- Filing date
- Dec 20, 2021
- Report date
- Dec 20, 2021
- Document
- form8k.htm
- Size
- 3.4 MB